Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
59.22
+0.63 (1.08%)
At close: Sep 17, 2025, 4:00 PM EDT
59.31
+0.09 (0.15%)
Pre-market: Sep 18, 2025, 5:49 AM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $3.68 billion as of September 18, 2025. Its market cap has increased by 47.89% in one year.
Market Cap
3.68B
Enterprise Value
3.02B
1-Year Change
47.89%
Ranking
Category
Stock Price
$59.22
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $3.68B, an increase of 2,048.19%. That is a compound annual growth rate of 40.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 3.65B | 58.44% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.96B |
| Johnson & Johnson | 426.78B |
| AbbVie | 389.99B |
| UnitedHealth Group | 308.04B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.70B |